Adherence to oral hormonal anticancer agents in breast cancer

There is an increasing trend towards using oral antitumoral agents in oncological patients. Compared to parenteral therapy, oral treatment offers convenience for both the patient and the healthcare system, with similar efficacy. However, the benefit deriving from oral drugs will be obtained only if...

Full description

Saved in:
Bibliographic Details
Published in:Tumori 2023-06, Vol.109 (3), p.262-268
Main Authors: Gori, Stefania, Modena, Alessandra, Foglietta, Jennifer, Verzè, Matteo, Inno, Alessandro, Casarin, Alessandra, Russo, Antonio, Nicolis, Fabrizio
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Antineoplastic Agents, Hormonal - therapeutic use
Breast Neoplasms - drug therapy
Chemotherapy, Adjuvant
Female
Humans
Medication Adherence
Mouth Neoplasms
Patient Compliance
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is an increasing trend towards using oral antitumoral agents in oncological patients. Compared to parenteral therapy, oral treatment offers convenience for both the patient and the healthcare system, with similar efficacy. However, the benefit deriving from oral drugs will be obtained only if patients adhere strictly to the treatment. Medical oncologists must therefore seek to optimize patient adherence. Breast cancer patients, particularly, are often treated with oral hormonal anticancer agents. In this review, we summarized evidence about adherence of breast cancer patients to oral hormonal anticancer agents and the consequences of poor compliance, the barriers to oral treatment and strategies to overcome them.
ISSN:0300-8916
2038-2529
DOI:10.1177/03008916221096183